The pharmaceutical intermediates market value is projected to grow from USD29 billion in 2021 and is projected to reach USD52.6 billion by 2030; it is expected to grow at a CAGR of 6.3% from 2021 to 2030.
The report contains 150+ pages with detailed analysis. The market report also covers the estimated market sizes and trends for different countries across major regions, globally.
The global pharmaceutical intermediates market is primarily driven by the rising burden of chronic diseases and growing geriatric population across the globe. The growing prevalence of chronic diseases such as cancer, leukemia, lymphoma, diabetes, and muscular degeneration are the major factors that propel the demand for the development of various drugs for the treatment. The growing geriatric population is fueling the demand for the drugs for the treatment of age related medical conditions across the globe.
Further, the rapid growth of the biotechnology industry is fostering the demand for the pharmaceutical intermediates for the manufacturing of wider range of medicines. The rising adoption of biopharmaceutical products among the global population due to its improved effectiveness and efficiency in the treatment of chronic ailments is fueling the growth of the global pharmaceutical intermediates market.
According to the International Agency for Research on Cancer, in 2020, around 19.3 million new cancer cases and 10 million cancer deaths were reported across the globe. Further, the geriatric population is expected to reach closer to 2 million by the year 2050. These numbers are the indicators of the increasing global demand for the various drugs across the globe, during the forecast period.
Download the Sample Pages of this Report for Better Understanding (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1356
The rising production of the active pharmaceutical ingredients is another driving force of the global pharmaceutical intermediates market. The growing trend of high-tech therapeutics coupled with the advanced delivery systems and development of personalized and customized drugs is boosting the demand for the active pharmaceutical ingredients across the globe. The pharmaceutical intermediates are used for the production of these APIs, and hence the rising production of APIs is driving the global pharmaceutical intermediates market.
The high costs associated with the acquisition of the biopharmaceutical drugs is a major factors that may indirectly impact the market growth in an adverse way. Moreover, high capital investments involved in the production of APIs is a major restraining factor that may hamper the market growth.
The introduction of latest technologies in the production of various medicines in the pharmaceutical industry and rising investments in the research activities are expected to provide various growth aspects to the market players in the upcoming future.
Research Objective
the market revenue/volume with the help of widespread quantitative and qualitative insights, and forecasts of the market. This report presents breakdown of market into forthcoming and niche segments. Additionally, this research study gauges market revenue growth and its drift at global, regional, and country from 2017 to 2020. This research report evaluates pharmaceutical intermediates market on a global and regional level. It offers thorough analysis of market status, growth and forecast of the global pharmaceutical intermediates market for the period from 2017 to 2030. This research study offers historic data for years 2017 to 2020 along with a forecast from 2021 to 2030 based on value.
This report also provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the pharmaceutical intermediates market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.
Report Scope of the Pharmaceutical Intermediates Market
| Report Highlights | Details |
| Market Size | USD 52.6 Billion by 2030 |
| Growth Rate | CAGR of 6.3% from 2021 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
North America dominated the global pharmaceutical intermediates market in 2020. This can be attributed to the increased investments on the development of biopharmaceutical industry. Moreover, the presence of numerous biotechnology companies and various CMOs and CROs are significantly contributing towards augmenting the demand for the pharmaceutical intermediates in the region. Further, regulatory bodies like FDA of US are ensuring standardization and good manufacturing practices of the companies involved that improves the credibility of the companies.
Asia Pacific is estimated to be the most opportunistic market owing to the increasing government expenditure on the development of pharmaceutical intermediate sector and development of sophisticated healthcare infrastructure. For instance,the Department of Pharmaceuticals prioritizes a list of 56 APIs under Make-in-India initiative. Further, China is the biggest importer of the APIs across the globe and hence, the demand for the pharmaceutical intermediates is high in China. Moreover, development of favorable foreign policies by the government to attract FDIs is expected to boost the market growth in this region.
Read Also: Circuit Protection Market Size Gain US$ 80.82 Billion by 2030
Based on the product, the bulk drug intermediates segment accounted for around 60% of the market share in 2020. The growing demand and production of APIs for the manufacturing of wide variety of drugs is boosting the growth of the bulk drug intermediate segment. The custom intermediates segment is projected to witness strong growth during the forecast period.
Based on the application, the anti-cancer drug segment is estimated to be the fastest-growing segment during the forecast period owing to the rising prevalence of various cancers such as breast cancer, lungs cancer, and colorectal cancer among the global population. The analgesics segment hit over 30% of market share in 2020.
Based on the end user, the CMOs/CROs dominated the market in 2020. The rapid growth of the contract manufacturing organizations and contract research organization in the developing and developed regions has significantly boosted the demand for the pharmaceutical intermediates for manufacturing vast variety of drugs and for the research purposes. The research laboratories segment is anticipated to witness fastest growth over the forecast period.
Some of the prominent players in the global pharmaceutical intermediates market include:
- Aceto Corporation
- BASF SE
- Chiracon GmbH
- Yin-sheng Bio-tech Co. Ltd.
- Dishman Group
- Green Vision Life Sciences
- Midas Pharma GmbH
- Sanofi SAIS
- Vertellus Holdings LLC.
- Lonza Group
Segments Covered in the Report
By Product
- Chemical Intermediates
- Bulk Drug Intermediates
- Custom Intermediates
By Application
- Analgesics
- Ant-inflammatory Drug
- Cardiovascular Drugs
- Anti-Diabetic Drugs
- Anti-Cancer Drugs
- Others
By End User
- Biotech & Pharma Companies
- Research Laboratory
- CMO/CRO
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmaceutical Intermediates Market
5.1. COVID-19 Landscape: Pharmaceutical Intermediates Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmaceutical Intermediates Market, By Product
8.1. Pharmaceutical Intermediates Market, by Product Type, 2021-2030
8.1.1. Chemical Intermediates
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Bulk Drug Intermediates
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Custom Intermediates
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Pharmaceutical Intermediates Market, By Application
9.1. Pharmaceutical Intermediates Market, by Application, 2021-2030
9.1.1. Analgesics
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Ant-inflammatory Drug
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Cardiovascular Drugs
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Anti-Cancer Drugs
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Anti-Diabetic Drugs
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Pharmaceutical Intermediates Market, By End User
10.1. Pharmaceutical Intermediates Market, by End User, 2021-2030
10.1.1. Biotech & Pharma Companies
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Research Laboratory
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. CMO/CRO
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Pharmaceutical Intermediates Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)
Chapter 12. Company Profiles
12.1. Aceto Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BASF SE
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Chiracon GmbH
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Yin-sheng Bio-tech Co. Ltd.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Dishman Group
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Green Vision Life Sciences
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Midas Pharma GmbH
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sanofi SAIS
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Vertellus Holdings LLC.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Lonza Group
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1356
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
